EUVIMEDOpdag EUVIMED
Crossref

Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects

M. D. Jaaffer, A. M. Chaloop

Biopolymers and Cell · 2026-04-24 · 42 (1) · 54-67

DOI: 10.7124/bc.000b2e ↗

At a glance

Journal article in Biopolymers and Cell, published on 2026-04-24. Written by M. D. Jaaffer and 1 co-authors. 27 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Cite

APA

Jaaffer, M. D., & Chaloop, A. M. (2026). Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects. Biopolymers and Cell, 42(1), 54-67. https://doi.org/10.7124/bc.000b2e

Vancouver

Jaaffer MD, Chaloop AM. Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects. Biopolymers and Cell. 2026;42(1):54-67. doi:10.7124/bc.000b2e

BibTeX
@article{Jaaffer2026,
  author = {Jaaffer, M. D. and Chaloop, A. M.},
  title = {Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects},
  journal = {Biopolymers and Cell},
  year = {2026},
  volume = {42},
  number = {1},
  pages = {54--67},
  doi = {10.7124/bc.000b2e}
}
Start for free →